elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36420683-78BDE267-589E-4F8F-9675-F8E40C01A47E
Q36420683-78BDE267-589E-4F8F-9675-F8E40C01A47E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36420683-78BDE267-589E-4F8F-9675-F8E40C01A47E
Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
P2860
Q36420683-78BDE267-589E-4F8F-9675-F8E40C01A47E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36420683-78BDE267-589E-4F8F-9675-F8E40C01A47E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e67d15c4f79c0ed75899c4238fa59aa57a21bef0
P2860
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.